Quick Answer
Odyssey Health, Inc. reported Research And Development Expense of $0.00 for the year ending 2025.
- Odyssey Health, Inc. showed a decrease of -100.0% in Research And Development Expense from 2024 to 2025.
- This data is from Odyssey Health, Inc.'s annual report (Form 10-K), filed with the SEC on October 29, 2025.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2015: $0.00 | Q1 2016: $0.00 | Q2 2016: $0.00 | Q4 2016: $0.00 | Q1 2017: $0.00 | Q2 2017: $0.00 | Q4 2017: $0.00 | Q4 2020: $0.00 | Q1 2021: $42.6 thousand | Q4 2021: $322.5 thousand | Q1 2022: $460.7 thousand | Q4 2023: $23.0 thousand | Q1 2024: $42.8 thousand | Q2 2024: $0.00 | Q4 2024: $0.00 | Q1 2025: $0.00 | Q2 2025: $0.00.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $55.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: